PEACCEL awarded by CIO Review
25 January 2021
PEACCEL has just been nominated as most promising biotech solutions providers in Europe 2021.
Click the links below for more details:
PRAXISforum Enzymes for Industrial Applications 2020, 4-5 February 2020, Frankfurt, Germany
3 February 2020
Meet PEACCEL at PRAXISforum Enzymes for Industrial Applications 2020.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
Protein Engineering Congress EU, 12-13 November 2019, Frankfurt am Main, Germany
18 October 2019
Meet PEACCEL at Protein Engineering Congress EU.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
Enzyme Engineering XXV, 15-19 September 2019, Whistler, British Columbia, Canada
14 September 2019
Meet PEACCEL at Enzyme Engineering XXV.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
14th International Symposium on Biocatalysis and Biotransformations (BioTrans 2019), 7–11 July 2019, Groningen, The Netherlands
5 July 2019
Meet PEACCEL at the Biotrans 2019.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
PEACCEL secures new funding.
20 March 2019
PEACCEL’s "Development of polypeptides by protein design" R&D program aims to develop a virtual platform for obtaining polypeptides with superior capacities, for the pharmaceutical and chemical industries.
Results: Virtual platform, proprietary molecules, POCs, and extension of international partnerships.
